|
Market Closed -
Sao Paulo
15:29:53 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 85.86 BRL | -0.42% |
|
+3.50% | +9.74% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
Chart calendar Vertex Pharmaceuticals Incorporated
Upcoming events on Vertex Pharmaceuticals Incorporated
| 2026-11-01 | Earnings presentation | |
| 2026-11-02 | Earnings release - Q3 2026 |
Past events on Vertex Pharmaceuticals Incorporated
| 2026-08-03 | Earnings presentation | 16:30 |
| 2026-08-03 | Earnings release - Q2 2026 | |
| 2026-05-13 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-05-13 | Annual General Meeting | 09:00 |
| 2026-05-04 | Earnings release - Q1 2026 | |
| 2026-05-04 | Earnings presentation | 16:30 |
| 2026-02-12 | Earnings presentation | 16:30 |
| 2026-02-12 | Earnings release - Q4 2025 | |
| 2025-11-08 | Information meeting | 20:00 |
| 2025-11-03 | Earnings release - Q3 2025 | |
| 2025-11-03 | Earnings presentation | 16:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9 869 9 861 0.08% | 11 020 10 879 1.3% | 12 001 11 982 0.16% | 13 248 | 14 551 | 16 439 |
|
EBITDA Million USD | Released Forecast Spread | 4 556 4 734 -3.75% | 903 882 2.4% | 5 473 5 588 -2.05% | 3 864 | 6 205 | 6 860 |
|
EBIT Million USD | Released Forecast Spread | 4 375 4 461 -1.94% | 696 678 2.65% | 5 263 5 349 -1.61% | 4 802 | 6 007 | 6 942 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 380 4 415 -0.8% | 249 289 -13.9% | 4 643 4 754 -2.32% | 4 551 | 5 785 | 6 888 |
|
Net income Million USD | Released Forecast Spread | 3 620 3 574 1.28% | -536 -419 -27.93% | 3 953 3 977 -0.61% | 2 535 | 4 836 | 5 698 |
|
EPS USD | Released Forecast Spread | 13,9 13,7 1.52% | -2,08 -1,59 -30.82% | 15,3 15,3 -0.13% | 9,73 | 18,5 | 21,9 |
| Announcement Date | 05/02/24 | 10/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 912 2 781 4.72% | 2 770 2 861 -3.17% | 2 965 2 907 2% | 3 076 3 059 0.56% | 3 190 3 175 0.48% | 2 987 2 998 -0.36% | 3 334 3 223 3.43% | 3 414 | 3 526 | 3 352 | 3 660 | 3 802 | 3 881 |
|
EBITDA Million USD | Released Forecast Spread | 1 245 1 212 2.75% | 1 231 1 313 -6.18% | 1 377 1 336 3.09% | 1 439 1 371 4.95% | 1 426 1 486 -4.04% | 1 366 1 333 2.49% | 1 480 1 449 2.12% | -1 229 | 1 315 | ||||
|
EBIT Million USD | Released Forecast Spread | 1 198 1 189 0.79% | 1 183 1 301 -9.08% | 1 325 1 290 2.74% | 1 385 1 383 0.16% | 1 370 1 471 -6.83% | 1 310 1 246 5.2% | 1 423 1 370 3.88% | 694 | 1 389 | 1 703 | 1 711 | 1 730 | 1 793 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 137 1 168 -2.68% | 730 1 201 -39.18% | 1 283 1 232 4.15% | 1 299 1 333 -2.55% | 1 331 1 423 -6.48% | 1 253 1 220 2.66% | 1 392 1 345 3.46% | 211 | 1 318 | 1 296 | 1 427 | 1 476 | 1 575 |
|
Net income Million USD | Released Forecast Spread | 913 927 -1.47% | 646 963 -32.9% | 1 033 985 4.81% | 1 083 1 057 2.43% | 1 191 1 193 -0.13% | 1 031 963 7.07% | 1 100 1 121 -1.91% | -968 | 1 068 | 1 176 | 1 231 | 1 258 | 1 323 |
|
EPS USD | Released Forecast Spread | 3,50 3,66 -4.27% | 2,49 3,76 -33.73% | 3,99 3,72 7.33% | 4,20 4,11 2.31% | 4,65 4,58 1.43% | 4,02 3,83 4.83% | 4,31 4,43 -2.76% | 2,10 | 4,21 | 4,08 | 4,48 | 4,96 | 4,98 |
| Announcement Date | 10/02/25 | 05/05/25 | 04/08/25 | 03/11/25 | 12/02/26 | 04/05/26 | 03/08/26 | - | - | - | - | - | - |
| 2026-10-02 |  | Ex-dividend date - 0.63 USD | 00:00 |
| 2026-10-02 | | Analyst/Investor Day | 01:00 |
| 2026-10-08 | | Ex-dividend date - 0.139 CNY | 00:00 |
| 2026-10-08 | | Sales and Revenue Release - Q3 2026 | 01:00 |
| 2026-10-08 | | Earnings presentation | 08:30 |
| 2026-10-08 | | Earnings release - Q1 2027 | |
| 2026-10-09 | | Extraordinary General Meeting | 02:30 |
| 2026-10-12 | | Earnings presentation | 01:00 |
| 2026-10-13 | | Earnings presentation | 08:30 |
| 2026-10-13 | | Earnings release - Q3 2026 |
Past sector events for Vertex Pharmaceuticals Incorporated
| Today | | Information meeting | |
| 2026-09-30 | | Annual General Meeting | 01:30 |
| 2026-09-30 | | Présentation aux Actionnaires / Analystes | 01:30 |
| 2026-09-30 | | Extraordinary General Meeting | 02:30 |
| 2026-09-30 | | Présentation aux Actionnaires / Analystes | 12:00 |
| 2026-09-30 | | Présentation aux Actionnaires / Analystes | 01:30 |
| 2026-09-30 | | Annual General Meeting | 01:30 |
| 2026-09-29 | | Ex-dividend date - 102 JPY | 00:00 |
| 2026-09-29 | | Ex-dividend date - 50 JPY | 00:00 |
| 2026-09-29 | | Ex-dividend date - 40 JPY | 00:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
- Calendar Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
